Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers
Miletić, D., Kraljević, M., Sokolović, E., Soče, M., Milović Kovačević, M., Bobić, S. ... Marijanović, I. (2023). Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers. Medical Science Monitor, 29.. doi: 10.12659/MSM.940356
Miletić, Dragana, et al. "Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers." Medical Science Monitor, vol. 29, 2023. https://doi.org/10.12659/MSM.940356
Miletić, Dragana, Marija Kraljević, Emir Sokolović, Majana Soče, Marijana Milović Kovačević, Simonida Bobić, Timur Cerić, Stjepko Pleština, Semir Bešlija and Inga Marijanović. "Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers." Medical Science Monitor 29 (2023). https://doi.org/10.12659/MSM.940356
Miletić, D., et al. (2023) 'Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers', Medical Science Monitor, 29. doi: 10.12659/MSM.940356
Miletić D, Kraljević M, Sokolović E, Soče M, Milović Kovačević M, Bobić S, and sur.. Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers. Medical Science Monitor [Internet]. 2023 May 17 [cited 2024 August 19];29. doi: 10.12659/MSM.940356
D. Miletić, et al., "Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers", Medical Science Monitor, vol. 29, May 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:134002. [Accessed: 19 August 2024]